Atherosclerosis is a chronic inflammatory disease driven by lipid accumulation in arteries,
leading to narrowing and thrombosis. It affects the heart, brain, and peripheral vessels and is …

Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …

Atherosclerosis, driven by chronic inflammation of the arteries and lipid accumulation on the
blood vessel wall, underpins many cardiovascular diseases with high mortality rates …

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed
countries, with an increasing prevalence due to an aging population. The pathology …

Atherosclerosis, a chronic cardiovascular disease caused by plaque development in
arteries, remains a leading cause of morbidity and mortality. Atherosclerotic plaques are …

Cardiovascular diseases are the leading cause of death worldwide. Despite preventive
efforts, early detection of atherosclerosis, the common pathophysiological mechanism …

Cardiovascular diseases (CVDs) are a primary cause of death globally. A few classic and
hybrid treatments exist to treat CVDs. However, they lack in both safety and effectiveness …

An external file that holds a picture, illustration, etc. Object name is bi-8-59-g004. jpg
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …

Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of
death in the world. Nanomedicine is a powerful tool that can be engineered to target …

Nanotechnology could improve our understanding of the pathophysiology of atherosclerosis
and contribute to the development of novel diagnostic and therapeutic strategies to further …